Category: Health Problems

Everything you need to know about Lyme disease

(HealthDay)—With growing concern about mosquito-borne viruses such as Zika, it’s easy to let down your guard when it comes to ticks. But Lyme disease is still a danger, especially in the Northeast and upper Midwest. In fact, it has affected people in almost every state. Lyme disease is spread through the bite of an infected

Artificial intelligence can diagnose PTSD by analyzing voices

A specially designed computer program can help diagnose post-traumatic stress disorder (PTSD) in veterans by analyzing their voices, a new study finds. Published online April 22 in the journal Depression and Anxiety, the study found that an artificial intelligence tool can distinguish—with 89 percent accuracy—between the voices of those with or without PTSD. “Our findings

Group, telephone, guided CBT treatment effective for depression

(HealthDay)—Group, telephone, and guided self-help cognitive behavioral therapy (CBT) formats are as effective as individual CBT for adult depression, according to research published online April 17 in JAMA Psychiatry. Pim Cuijpers, Ph.D., from Vrije Universiteit Amsterdam, and colleagues conducted a network meta-analysis on randomized clinical trials of CBT for adult depression to examine the most

Immune responses in Ebola survivors 2 years after infection provide clues for vaccine development

Scientists have discovered that 2 years after infection, West African Ebola survivors exhibit memory immune responses—including specific T cells against Ebola virus. They believe their discovery opens up the possibility of improving Ebola vaccines by boosting key immune cells needed for long-lasting protective immunity. The new research is being presented at this year’s European Congress

How our sense of taste changes as we age

Taste is a complex phenomenon. We do not experience the sensation through a single sense (as we would when we see something using our sense of sight, for example) but rather it is made up of the five senses working together to allow us to appreciate and enjoy food and drink. Initial visual inspection of

Cardiac-specific comorbidity index beats generic indexes

(HealthDay)—For patients admitted to the hospital with a cardiac condition, a cardiac-specific comorbidity index outperforms generic indexes for predicting mortality, according to study published online March 18 in CMAJ, the journal of the Canadian Medical Association. Lorenzo Azzalini, M.D., Ph.D., from the Université of Montréal, and colleagues derived a cardiac-specific comorbidity index from consecutive patients

Discovery of a host mRNA that inhibits immune functions of antiviral protein RIG-I

Hepatitis C virus (HCV) is a hepatotropic virus, with about 80 million chronic infections confirmed worldwide. HCV infection leads to the development of chronic hepatitis, cirrhosis, and in some instances, hepatocellular carcinoma. The recent development of highly potent direct-acting antiviral drugs (DAAs), targeting viral proteins, facilitates virus elimination in >90 percent of treated individuals. However,

Fintepla

EMERYVILLE, Calif., April 08, 2019 (GLOBE NEWSWIRE) — Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it received a Refusal to File (RTF) letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for Fintepla (ZX008, fenfluramine hydrochloride) for the treatment of seizures

Gene editing for recessive dystrophic epidermolysis bullosa: A little bit closer to clinical applications

A group of researchers from the Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) (Biomedical Research Networking Centre on Rare Diseases), Universidad Carlos III de Madrid (UC3M), the Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) (Research Center for Energy, Environmental and Technology), and the Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD)

New tools and strategies for tuberculosis diagnosis, care, and elimination: A PLOS Medicine special

This week, publication of a special issue on tuberculosis (TB) begins in PLOS Medicine, advised by guest editors Richard Chaisson of Johns Hopkins University, Claudia Denkinger of the University of Heidelberg, and Mark Hatherill of the South African Tuberculosis Vaccine Institute. An estimated 10 million people developed tuberculosis (TB) and 1.6 million died of TB

Most links between personality traits and life outcomes are replicable

Studies showing links between personality traits and life outcomes, such as marital stability and vocational achievements, provide a reasonably accurate map of the relationship between personality and various aspects of one’s life, according to findings from a large-scale replication project. The findings are published in Psychological Science, a journal of the Association for Psychological Science.

The risks of infectious mononucleosis

Infectious mononucleosis, or mono, sidelines high school athletes every year. Kids who play sports aren’t more susceptible to the disease. Instead, adolescent competitors are at a greater risk for one of the illness’s serious complications—splenic rupture. Mono starts with fatigue, sore throat, fever and swollen glands. By then, it’s invaded the lymphatic system, which can

Study illuminates the brain’s inner workings

Like instruments in an orchestra, different parts of the human brain work together to help us perform the functions of daily life, ranging from breathing and sleeping to reading, walking and learning. But which areas of the brain work in harmony to accomplish certain types of tasks? And how does this coordination vary from person

A soft spot for stem cells helps cornea healing

New research led by scientists at Newcastle University, UK reveals a potential revolutionary way to treat eye injuries and prevent blindness—by softening the tissue hosting the stem cells which then helps repair wounds, inside the body. The team discovered that the simple application of a tissue-softening enzyme, collagenase, prevents the loss of corneal stem cells